# Restylane Silk Acne Scar Efficacy Evaluation Study

> **NCT02955381** · NA · TERMINATED · sponsor: **Schweiger Dermatology, PLLC** · enrollment: 26 (actual)

## Conditions studied

- Acne
- Acne Scars
- AdverseEvent

## Interventions

- **DEVICE:** Restylane Silk, 1.0 ml
- **DEVICE:** Saline, 1.0 ml

## Key facts

- **NCT ID:** NCT02955381
- **Lead sponsor:** Schweiger Dermatology, PLLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-28
- **Primary completion:** 2019-04-18
- **Final completion:** 2019-04-18
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Liquidation of Research Department
- **Last updated:** 2019-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955381, "Restylane Silk Acne Scar Efficacy Evaluation Study". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02955381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*